Results 271 to 280 of about 106,112 (301)

Tocilizumab

Reactions Weekly, 2023
  +8 more sources

Tocilizumab

Reactions Weekly, 2018
  +7 more sources

Tocilizumab

Reactions Weekly, 2017
  +8 more sources

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet, The, 2021
Naseer Ahmed, Mohammad Ali, Syed Ali
exaly  

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Nature Medicine, 2022
Felice Rivellese, Anna Elisa Surace, Katriona Goldmann   +2 more
exaly  

Tocilizumab

Reactions Weekly, 2015
  +6 more sources

Tocilizumab

Reactions Weekly, 2022
openaire   +2 more sources

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Lancet, The, 2021
Frances Humby, Patrick Durez, Maya H Buch   +2 more
exaly  

Effective treatment of severe COVID-19 patients with tocilizumab

Proceedings of the National Academy of Sciences of the United States of America, 2020
Mingfeng Han, Dongsheng Wang, Binqing Fu
exaly